SCHEMBL4908496

SCHEMBL4908496

CCN(c1nc(-c2ccc(C)cc2)sc1C)S(=O)(=O)c1ccc(C(C)C)c(C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.42
MCL1 Q07820 6/20 0.40
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
BCL2L1 Q07817 4/20 0.38
KDM4E B2RXH2 3/20 0.37
RAB9A P51151 2/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 2/20 0.37
TRPM8 Q7Z2W7 2/20 0.36
NR1H4 Q96RI1 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904191 0.94 LMNA (0.42) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4905802 0.94 LMNA (0.45) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4906208 0.92 ALDH1A1 (0.41) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4898146 0.91 LMNA (0.41) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4903740 0.91 ALDH1A1 (0.41) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4901463 0.89 ALDH1A1 (0.44) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4905813 0.89 TRPM8 (0.50) TRPM8
SCHEMBL4906947 0.89 LMNA (0.46) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4906621 0.89 ALDH1A1 (0.43) ALDH1A1HPGDALOX15HSD17B10LMNA
SCHEMBL4903647 0.85 ALDH1A1 (0.39) ALDH1A1HPGDALOX15HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885HPGD 724/4885ALOX15 1494/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885HPGD 724/4885ALOX15 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.